Higher AXIN1 protein levels associated with significantly decreased risks of total number of infections, cold, pneumonia, tonsillitis and fever episodes, and asthma risk in COPSAC2010 and a significantly decreased risk of respiratory infections in EMIL suggesting a protective effect of this specific protein in both cohorts. This evidence concerns the gene AXIN1 and respiratory tract infectious disorder.